Latest GUSTO data tips balance back to angioplasty
This article was originally published in Clinica
Executive Summary
The final results of the GUSTO-2b(*) substudy, which compared primary angioplasty with thrombolysis in heart attack patients, now suggest that angioplasty is significantly better. The final results were presented at the European Society of Cardiology meeting in Birmingham by Dr Amadeo Betriu from the Provincial Hospital Clinica in Barcelona. Dr Betriu emphasised that the benefit is small, despite its statistical significance. The composite event rate for thrombolysis patients was 13.7% compared with 9.6% for primary angioplasty.
You may also be interested in...
EWG Study Suggests More Than One In 10 Talc-Based Cosmetics Contain Asbestos
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Atlas Biomed Unlocking Japan’s OTC Market With Direct-To-Consumer DNA And Microbiome Tests
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
Hair Supplement Linked To Cases Of Severe Hepatitis In France
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: